Puerperal influence of bovine uterine health status on the mRNA expression of
pro-inflammatory factors by Peter, S. et al.
INTRODUCTION
Endometritis in the postpartum period is one of the most
prevalent disorders in high producing dairy cows (1, 2). This is
associated with a negative impact on reproductive performance
resulting in decreased conception rates, prolonged calving
intervals, reduced milk yield and higher culling rates (3-5). A
main cause for endometritis is the invasion of aerobic and
anaerobic bacteria into the bovine uterus during and after
parturition due to the disintegration of anatomical barriers (6-8).
Endometrial luminal epithelial cells react by recognizing
invading pathogens (9) and support the immune system with the
production of pro-inflammatory factors such as cytokines and
chemokines (10).
Chemokines are chemotactic proteins that play a central role
in the initiation of the innate immune response regulating the
migration of immune cells to the site of infection. This early
recruitment of polymorphonuclear neutrophils (PMN) is
essential for the containment of pathogens (11). The chemokine
(C-X-C motif) ligands 1 (CXCL1), CXCL2, CXCL3 and
CXCL5 are strong chemoattractants that all bind to the
chemokine receptor 2 (CXCR2) and stimulate the recruitment
and activation of neutrophils (12, 13). CXCL5 could already be
emerged as a time-dependent modulator in the course of the
postpartum period and is involved in immunoregulatory
processes in case of subclinical or clinical endometritis (14, 15).
Another potent chemoattractant of PMN that also binds to
CXCR2 is interleukin 8 (IL8) (16). Its mRNA expression was
observed to be dependent on the health status of the bovine
endometrium along with other pro-inflammatory cytokines such
as IL1A, IL1B, IL6 and tumor necrosis factor (TNF) (15, 17, 18).
Besides chemokines and cytokines, prostaglandins (PGs) are
another group of important inflammatory mediators in addition
to their contribution to a diversity of physiological reproductive
events. In previous studies, the expression of enzymes of the PG
synthesis such as prostaglandin-endoperoxide synthase 2
(PTGS2), prostaglandin E synthase 3 (PTGES3) and
prostaglandin D2 synthase (PTGDS) was linked to the health
status of the puerperal bovine uterus (14, 19).
Furthermore, a potent phospholipid mediator of intercellular
signaling in case of inflammation is the platelet-activating factor
(PAF) (20). It is synthesized by a broad range of cell types and
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After parturition, uterine bacterial infections lead to inflammatory processes such as subclinical/clinical endometritis with
high prevalence in dairy cows. Endometrial epithelial cells participate in this immune response with the production of pro-
inflammatory factors. The objective of the present study was to evaluate the endometrial mRNA expression pattern of pro
inflammatory factors during a selected postpartum (pp) period. Dairy cows with three different uterine health conditions
on days 24-30 pp (healthy: n = 11, subclinical endometritis: n = 10, clinical endometritis: n = 10) were sampled using the
cytobrush technique. Subsequently, each cow was sampled 3 more times in weekly intervals (days 31-37 pp; days 38-44
pp; days 45-51 pp). Samples were subjected to mRNA analysis performed by RT-qPCR. Additionally, an analysis of
cultivable bacteria was performed at the early/late stage of the selected puerperal period. mRNA expression of 16
candidate genes was analyzed by using two different approaches. The first approach referred to the initial grouping on
days 24-30 pp to reveal long-term effects of the uterine health on the subsequent puerperal period. The second approach
considered the current uterine health status at each sampling to elucidate the impact of different points in time. Long-term
effects seem to appear for chemokines, prostacyclin synthase and prostaglandin D2 synthase. If related to the current
uterine health, the majority of candidate genes were significantly higher expressed in endometritic cows on days 45-51
pp in contrast to earlier stages of the puerperium. Microbiological analysis revealed the significantly higher prevalence of
Trueperella pyogenes findings in cows with clinical endometritis on days 24-30 pp, but no correlations were found on
days 45-51 pp. In conclusion, a strong immune response to subclinical/clinical endometritis in the late puerperium may
be related to the negative impact of these conditions on reproductive performance in dairy cows.
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activates a variety of cells including endometrial and immune
cells by binding to the corresponding receptor (PTAFR) (21, 22).
In combination with the activation of potent pro-
inflammatory factors, pathological events such as bacterial
invasion of the uterus require repair mechanisms for the tissue.
Matrix metallopeptidase 1 (MMP1) is an enzyme involved in the
remodelling of tissue stimulated by pro-inflammatory cytokines
(23).
The capability of the puerperal bovine endometrium for a
sufficient immune response to uterine infection, cellular
mechanisms and the involvement of pro-inflammatory factors
are still a matter of interest and intensive research.
Therefore, the objective of the present study was to elucidate
the mRNA expression pattern of candidate genes during the
postpartum (pp) period in bovine endometrial samples taken at
four points in time starting on days 24-30 pp. Two statistical
approaches were performed with the obtained data: 1) analyzing
possible long-term effects of the initial uterine health condition
(healthy, subclinical endometritis and clinical endometritis) and
2) analyzing the influence of the actual bovine uterine health
status at each point in time of sampling.
MATERIALS AND METHODS
Examination and classification of cows
Lactating Holstein cows included in this study were kept on
a dairy farm in Brandenburg (Germany) housing around 200
cows in accordance with the guidelines of the National Animal
Welfare Legislation.
At the first examination (Exam 1 [E1]) on days 24-30 pp,
cows were carefully examined by inspection of the vulva,
vaginoscopy, transrectal palpation and ultrasonography (Tringa
Linear, Esaote, Germany) of the uterus and ovaries. Only cows
(n = 31; 7 primiparous and 24 multiparous) that were not
showing signs of estrus (presence of a Graafian follicle and/or
discharge of clear and cohesive mucus from the vulva) were
included in this study.
At E1, cows were divided into 3 groups dependent on the
health status of the uterus (24).
With signs of clinical endometritis (purulent or
mucopurulent uterine discharge detectable in the vagina), cows
were enrolled in the first group (Clinical Endometritis [CE]; n =
10).
The second group included cows with subclinical
endometritis (Subclinical Endometritis [SCE]; n = 10). These
cows had no (muco)purulent discharge in the vagina, but the
content of PMN in the cytological sample was ≥ 5% (19).
No (muco)purulent discharge and a PMN content of <5%
classified cows as healthy (Healthy [H]; n = 11) and they were
enrolled in the third group.
Each cow was examined three more times in weekly
intervals in the same manner as done at E1 (days 24-30 pp).
These examinations were performed on days 31-37 pp (Exam 2
[E2]), on days 38-44 pp (Exam 3 [E3]) and on days 45-51 pp
(Exam 4 [E4]). After the examination of each cow, endometrial
samples were collected at E1, E2, E3 and E4 as described below.
The first approach of analysis was to evaluate a long-term
effect of the uterine health status at E1 on the subsequent mRNA
expression pattern of the candidate genes. Therefore, cows were
classified into the health groups at E1 as described above and
this initial grouping remained for E2, E3 and E4.
The second approach of analysis considered the fact that the
uterine health status of most cows changed after E1. Therefore,
the cows were reclassified into groups considering their current
uterine health at each point in time of sampling after E1. These
are the same points in time of examination (E2, E3 and E4), but
for the analysis the denotation was changed to Exam 2 Current
Health (E2CH on days 31-37 pp), Exam 3 Current Health
(E3CH on days 38-44 pp) and Exam 4 Current Health (E4CH on
days 45-51 pp). This new labeling was done to distinguish this
second approach of analysis from the first approach.
The stage of the estrous cycle was specified
ultrasonographically. At E1, a corpus luteum was detectable in
22 cows (luteal phase). Without the presence of a corpus luteum
and a Graafian follicle at E1, cows were considered to be prior
to their first estrus phase after parturition (n = 9). Considering
the status of the estrous cycle at the following points in time of
sampling, only 9 cows were ultrasonographically classified as
not being in the luteal phase due to the absence of a corpus
luteum and the presence of a Graafian follicle. Seven of these
cows were classified as being in pro-estrus (three cows at
E2/E2CH, three cows at E3/E3CH and one cow at E4/E4CH)
and two cows as being in estrus (one cow at E2/E2CH and one
cow at E3/E3CH).
The cows showing signs of clinical endometritis at E1 were
injected intra muscular with 25 mg PGF2α (Dinolytic, Pfizer,
Berlin, Germany) at E1 and E3 after sampling.
Collection of endometrial samples
Endometrial epithelium samples were obtained by using the
cytobrush technique (19, 25). Briefly, the vulva was cleansed
with dry paper towel. A sterile cytobrush (Celltip, Servoprax,
Wesel, Germany), screwed on a 55 cm long rod, was inserted
into the uterine body through a sterile metallic catheter, which
was protected by a plastic cover (Hygienic Sheath, Minitube,
Tiefenbach, Germany) to avoid contaminations from the vulva
and vagina. Using a new cytobrush each time, separate samples
were taken from each cow first for cytological analysis, second
for microbiological analysis (at E1 and E4/E4CH) and third for
isolation of RNA.
Cytological slides were prepared on the farm by rolling the
cytobrush on a clean glass microscope slide. After transportation
to the laboratory, the air-dried cytology slides were fixed and
stained with the Hemacolor staining set (Merck, Darmstadt,
Germany) following the manufacturer's protocol. All slides were
examined in a meandering pattern by light microscopy (Zeiss,
Axioskop, Oberkochen, Germany) at ×1000 magnification with
oil. A total of 300 cells (endometrial epithelial cells, PMNs and
lymphocytes) were counted to determine the percentage of
PMN. Cows without (muco)purulent discharge were defined as
having SCE with a PMN content of ≥ 5% or as being healthy (H)
with a PMN content of <5% (19).
The cytobrush for microbiological analysis was placed in an
Amies medium containing tube (Heinz Herenz, Hamburg,
Germany) and transported at room temperature to the laboratory.
For mRNA analysis, one cytobrush was placed in a cryotube,
which was immediately immersed into liquid nitrogen and
stored at -80°C until use.
Microbiological analysis
The cytobrush samples were analyzed by aerobic and
anaerobic cultivation after direct inoculation of the cytobrush
with the suitable agar plates and also after the enrichment in a
medium with subsequent cultivation on agar (all agar purchased
from Oxoid, Wesel, Germany).
For the detection of aerobic bacteria, Columbia blood agar
(5% sheep blood), Gassner agar and Brilliance UTI Clarity agar
were inoculated with the cytobrush within 12 hours after
sampling for 24-48 hours (aerobic, 36°C). For the evaluation of
the presence of obligate anaerobic bacteria, the inoculation was
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carried out on Columbia blood agar (5% sheep blood) with
added L-cysteine (Merck), haemin (Sigma-Aldrich, Hamburg,
Germany), vitamin K1 (Roche, Mannheim, Germany) and lysed
sheep blood 0.5% (Oxoid) and on an additionally plate with the
same agar and added gentamicin (Hexal, Holzkirchen,
Germany), both for 48-72 hours (anaerobic, 36°C). Chocolate
agar was used for cultivation of fastidious bacteria for 24-48
hours (36°C, microaerobic, 7% CO2). In addition, an enrichment
culture with brain heart infusion broth (Oxoid) was started from
each cytobrush at 37°C for 24 hours, which was transferred to
Columbia blood agar (5% sheep blood).
The identification of the species was carried out by Gram
stain, oxidase and catalase tests according to standard protocols
(26) and API strips (bioMérieux, Nürtingen, Germany).
Extraction of total RNA and reverse transcription
Total RNA was extracted from cytobrush samples by using
the RNeasy Plus Mini Kit (Qiagen, Hilden, Germany). The first
steps of the manufacturer's protocol were slightly modified by
adding the lysis buffer directly to each cytobrush and subsequent
thoroughly vortexing to disrupt cells. The cytobrush was
removed with clean forceps and the remaining sample was then
processed as described in the manufacturer's protocol. The yield
of obtained total RNA was quantified by spectrophotometry at
the wavelength of 260 nm. Samples were stored at –80°C until
further use.
To validate the integrity of RNA, 1 µl of total RNA was
loaded onto a RNA 6000 Nano Chip using the Agilent 2100
Bioanalyzer (Agilent Technologies, Waldbronn, Germany)
following the manufacturer's protocol.
100 ng total RNA per sample was used to generate single
stranded cDNA by using 200 U RevertAid Reverse
Transcriptase and 2.5 µM random hexamer primers (both
Thermo Scientific, Schwerte, Germany) in a total volume of
60 µl (27). Before reverse transcription, a DNase treatment
was performed for the removal of genomic DNA (28).
Samples without addition of reverse transcriptase were also
prepared as negative controls to confirm the absence of any
genomic DNA or contaminations. Samples were stored in
aliquots at -20°C until further analysis.
Real-time polymerase chain reaction (PCR)
To assess the mRNA expression of the candidate genes,
quantitative real-time PCR was performed as previously
reported (27) following the minimum information for
publication of quantitative real-time PCR experiments (MIQE)
guidelines (29). The used primer pairs were synthesized by
Eurofins MWG Operon (Ebersberg, Germany) and are listed in
Table 1. Unpublished primer pairs were first evaluated by a
gradient-PCR to determine the optimal annealing temperature
and obtained PCR products were submitted to commercial DNA
sequencing (GATC Biotech, Konstanz, Germany) for
confirmation of 100% homology to the published bovine
sequences (27).
A total reaction volume of 10 µl per sample for real-time
PCR contained 1 µl cDNA, 0.4 µM of each primer (forward and
reverse; details given in Table 1) and 5 µl 2× SensiMix SYBR
Low-ROX (Bioline, Luckenwalde, Germany). Amplification
was carried out using the Rotor Gene 3000 (Corbett Research,
Mortlake, Australia) and the following protocol. A denaturation
step of 95°C for 10 min was followed by a three-step
amplification in 45 cycles (except 25 cycles for 18S rRNA):
denaturation at 95°C for 15 s, annealing for 20 s (temperatures
are indicated in Table 1) and extension at 72°C for 30 s. A
subsequent melting curve program (50-99°C) with continuous
fluorescence measurement was carried out to confirm specific
amplification followed by a final cooling step to 40°C. A dilution
series with known concentrations of the purified specific PCR
products was amplified simultaneously to generate a standard
curve. Rotor Gene 6.1 software (Corbett Research) was used to
calculate the contents of specific mRNA in comparison with the
standard curves.
Statistical analysis
Using the geNorm tool, 18S ribosomal RNA (18S rRNA) and
suppressor of zeste 12 homolog (SUZ12) were chosen to
normalize the expression of the genes of interest for each sample
(30) and inter-run calibration was performed based on 10 inter-
run calibrator samples (31). Normalized and calibrated values
were used to generate box plots, which are presenting the
median values with 50% of all data within the box.
Normal distribution was tested with the Shapiro-Wilk test.
Neither the percentages of the PMN nor the values of any of the
genes of interest were normally distributed.
Normalized and calibrated values were analyzed by the
Mann-Whitney U test to compare samples from healthy cows
with samples from cows with either subclinical or clinical
endometritis at each point in time of examination. The level of
significance was set at P < 0.05.
Fold changes were calculated as the approximate ratio of the
mean value of normalized mRNA expression for the SCE or CE
group to the mean value of the H group, respectively.
Correlations between the content of PMN with the selected
factors as well as between each of the factors was calculated by
the Spearman-rho test with the level of significance set at P < 0.01.
The Fisher's exact test was used to calculate the prevalence
of Trueperella pyogenes and Escherichia coli in the group with
purulent vaginal discharge (CE) in relation to the groups without
purulent vaginal discharge (H and SCE) with P < 0.05.
All statistical evaluations and the generation of the box plots




The evaluation of the aerobic cultivation of the cytobrush
samples taken at E1 and E4CH revealed that specific pathogenic
bacteria (e.g. E. coli, T. pyogenes) could not always be detected
in the SCE and CE group.
At E1, E. coli was cultivable from only few samples of all
groups. In detail, E. coli was detected in one sample of the H
group, in three samples of the SCE group and in one sample
from a cow with CE. T. pyogenes was not detected in the SCE
group at E1, but in one sample of the H group and in four
samples from cows with CE, which signifies a higher prevalence
of T. pyogenes findings in cows with CE (P = 0.027).
At E4CH, no specific pathogenic bacteria were cultivable
except E. coli in one cow of the SCE group (along with Aerococcus
sp. and Lactobacillus sp.) and in one cow of the H group.
All five cows that were tested positive for E. coli at E1, even
if they had SCE or CE, were healthy at the following
examinations. In contrast, all five cows that had T. pyogenes
cultivated from their cytobrush sample at E1, showed signs of
subclinical or clinical endometritis at the following
examinations with only one exception at E3CH when this cow
was classified as healthy.
Additionally, aerobic cultivation revealed the sporadic












For 5'-GAG AAA CGG CTA CCA CAT CCA A-3'18S rRNA
Rev 5'-GAC ACT CAG CTA AGA GCA TCG A-3'
(27) 337 bp 61ºC
For 5'-TTC GTT GGA CAG GAG AGA CC-3'SUZ12
Rev 5'-GTG CAC CAA GGG CAA TGT AG-3'
NM_001205587 286 bp 60ºC
For 5'-GAC CTT GCA GGG GAT TCA CCT C-3' CXCL1/2 
Rev 5'-CGG GGT TGA GAC ACA CTT CCT G-3' 
(54) 125 bp 60ºC 
For 5’-GCC ATT GCC TGC AAA CTT-3’ CXCL3 
Rev 5’-TGC TGC CCT TGT TTA GCA- 3’ 
(54) 189 bp 56ºC 
For 5’-TGA GAC TGC TAT CCA GCC G- 3’ CXCL5 
Rev 5’-AGA TCA CTG ACC GTT TTG GG- 3’ 
(15) 193 bp 61ºC 
For 5'-AAC AGA CTC TGC CCC ATG TC-3' CXCR2
Rev 5'-AGT GAC AGA GCG ACC AAT CC-3' 
(54) 151 bp 60ºC 
For 5'-TCA TCC ACC AGG AAT GCA TC-3' IL1A 
Rev 5'-AGC CAT GCT TTT CCC AGA AG-3' 
(19) 300 bp 59ºC 
For 5’-CAA GGA GAG GAA AGA GAC A- 3’ IL1B 
Rev 5’-TGA GAA GTG CTG ATG TAC CA- 3’ 
(55) 236 bp 56ºC 
For 5'-TCC AGA ACG AGT ATG AGG-3' IL6
Rev 5'-CAT CCG AAT AGC TCT CAG-3' 
(55) 236 bp 56ºC 
For 5'-CGA TGC CAA TGC ATA AAA AC-3' IL8 
Rev 5'-CTT TTC CTT GGG GTT TAG GC-3' 
(15) 153 bp 56ºC 
For 5'-CAG ATG CGG AGT TTC TGA GTC G-3' PTGS1 
Rev 5'-GGG TAG TGC ATC AGC ACG G-3' 
(27) 313 bp 60ºC 
For 5'-CTC TTC CTC CTG TGC CTG AT-3' PTGS2 
Rev 5'-CTG AGT ATC TTT GAC TGT GGG AG-3' 
(27) 359 bp 60ºC 
For 5’-CTG TTG TCC CCA ACC AGG-3’ PTGIS 
Rev 5’-CTG TCC AGC ACA GGC ATG-3’ 
NM_174444  311 bp 60ºC 
For 5’-TGC AAA GTG GTA CGA TCG G-3’ PTGES3 
Rev 5’-TAA CCT TGG CCA TGA CTG G-3’ 
(19) 253 bp 61ºC 
For 5’-TGA GAC GCG GAC CTT ACT G-3’ PTGDS 
Rev 5’-CTG GGA GCG GCT GTA GAG-3’ 
(19) 193 bp 61ºC 
For 5’-CAA GTA ACA AGC CGG TAG CC-3’ TNF 
Rev 5’-GCT GGA AGA CTC CTC CCT G -3’ 
(56) 354 bp 60ºC 
For 5’-GAT GAT GAT GAA TGG TGG ACC-3’ MMP1 
Rev 5’-TCC ACT TCT GGG TAC AAG GG-3’ 
(57) 347 bp 60ºC 
For 5’-CAA CCA GGG TGA CTG GAT TC-3’ PTAFR 
Rev 5’-GGA AAA TGT GGA TGG TGA GG-3’ 
NM_001040538 338 bp 59ºC 
  
Table 1. Selected gene transcripts, primer sequences and annealing temperatures used for RT-qPCR with resulting amplicon length.
E1 and in one cow at E4CH, of Streptococcus uberis in one cow
of the H group at E4CH and of Staphylococcus sp. in one cow
of the CE group at E1.
The result of the anaerobic cultivation showed no cultivable
bacteria in the H and SCE groups (except Clostridium
perfringens in one SCE cow at E4CH). At E1, Prevotella sp. and
P. melaninogenica were cultivable each in one cow with CE
associated with the presence of T. pyogenes.
Current uterine health status at each sampling
The current uterine health status of each of the cows at each
sampling is shown in Fig. 1.
Subsequent to E1, the number of cows in the groups
dependent on their current uterine health was distributed as
follows (H/SCE/CE): E2CH (n = 17/3/11), E3CH (n = 20/5/6)
and E4CH (n = 16/8/7).
Most of the cows that were classified healthy at E1 were
found in that same uterine health group continuously later in the
puerperium. The majority of cows that had SCE at E1 were
found in the healthy group at E2CH. In contrast, all of the five
cows that were found in the SCE group at E3CH were also
found in that group one week later. None of the cows
continuously had subclinical endometritis. Most of the cows
with CE at E1 were diagnosed with SCE or CE in the following
puerperal period.
mRNA expression analysis
Endometrial epithelial mRNA expression of all selected
candidate genes was detected in all uterine health groups and at
all points in time of sampling. However, mRNA expression for
PTGS1, PTGS2, PTGIS, IL1A, IL6, TNF and MMP1 could not
be found in each sample. In the following text, mainly
significant differences in normalized mRNA expression are
described.
The status of the estrous cycle from totally 124
examinations (luteal phase: n = 103, prior to first ovulation: n =
12, pro-estrus: n = 7, estrus: n = 2) did not have a statistical
significant influence on the mRNA expression values.
mRNA expression of key enzymes of the prostaglandin
synthesis
No differential mRNA expression for the analyzed enzymes
of the prostaglandin synthesis in the endometrial epithelium was
detected on days 24-44 pp if the current uterine health status was
considered. However, differences were found at the last
examination (E4CH) for the mRNA expression of PTGS1 and
PTGS2. A fourfold higher expression (P = 0.042) was observed
for PTGS1 mRNA in the SCE group and for PTGS2 mRNA in
the CE group (P = 0.023), both compared with healthy cows
(Fig. 2A and 2B).
The mRNA expression of PTGES3 did not reach any statistical
differences between the groups of current uterine health at any
point in time (Fig. 2C), also not for days 31-51 pp if evaluated
referring to the initial grouping (E2, E3, E4; data not shown).
Following up the same cows dependent on the initial
grouping at E1, no significant differences in PTGIS contents
were found at E2 and E4. However at E3, PTGIS mRNA
expression was eightfold higher (P = 0.009) in the CE group if
compared with the H group (Fig. 3A). A similar expression
pattern was found for PTGDS mRNA at the same time of
sampling (ninefold higher; P = 0.001) with an additional
threefold higher expression (P = 0.049) in the SCE group in
comparison to the H group (Fig. 3B). At E2, the PTGDS
transcript amount was also twofold higher (P = 0.011) in cows
with CE in relation to healthy cows. Considering the actual
health status at E4CH, PTGDS mRNA was higher expressed in
both SCE (tenfold higher; P = 0.012) and CE (fivefold higher; P
= 0.009) groups compared with cows of the H group.
mRNA expression of chemokines and their receptor
Sequences for CXCL1 and CXCL2 are to 99% homologous.
Obtained sequences for the amplicons are to 100% homologous
to CXCL1 and CXCL2. Therefore, the primers named CXCL1/2
were specific for CXCL1 as well as for CXCL2.
At E1, CXCL1/2 was fivefold higher (P = 0.011) expressed
in SCE cows compared with H cows (Fig. 4A). Retaining the
grouping from E1, the mRNA expression was sixfold higher (P
= 0.029) in endometrial epithelium cells from cows with CE in
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Fig. 1. Change of the uterine health status (H:
healthy cow; SCE: cow with subclinical
endometritis; CE: cow with clinical endometritis) of
each of the cows over the period of sampling. E1 -
days 24-30 pp; E2CH - days 31-37 pp; E3CH - days





















































































Fig. 2. Normalized mRNA expression of (A)
PTGS1, (B) PTGS2 and (C) PTGES3 in bovine
endometrial cytobrush samples harvested from
dairy cows depending on the current status of
uterine health (H:  healthy, SCE: subclinical
endometritis, CE - clinical endometritis) on days
24-30 pp (E1), on days 31-37 pp (E2CH), on
days 38-44 pp (E3CH) and on days 45-51 pp
(E4CH). Bold asterisks over dotted lines
indicate significant differences between the
groups (P < 0.05). Extreme values are
diagrammed as asterisks, outliers as circles.
Extreme values are not shown for PTGS1 (9.02
and 9.76) obtained from two cows of the H
group at E2CH.
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comparison to the H group at E4. If the cows were classified
dependent on their current health status at the time of sampling,
the pattern for CXCL1/2 mRNA additionally showed a
significant correlation to the uterine health at E4CH both
regarding SCE cows (threefold higher; P = 0.012) and CE cows
(about 20-fold higher; P = 0.009) compared with the H group.
CXCL3 reached a twofold higher expression (P = 0.002) in
CE cows compared with H cows at E1 and almost similar at
E4CH (threefold higher; P = 0.013) considering the actual
uterine health status (Fig. 4B).
Comparing transcript amounts of the CE group to the H
group, CXCL5 mRNA was significantly higher expressed at E1
(fivefold higher; P = 0.011), at E2CH (sixfold higher; P = 0.02),
at E4 (sevenfold higher; P = 0.029) and at E4CH (20-fold higher;
P = 0.016) (Fig. 4C). No differences were observed for CXCL3
and CXCL5 if comparing the SCE group to the H group.
The CXCR2 mRNA expression pattern showed significant
differences (P < 0.05) between the same groups as shown for
CXCL1/2, with the addition that CXCR2 was 30-fold higher
expressed (P = 0.014) in SCE cows in relation to H cows at
E3CH (Fig. 4D).
mRNA expression of interleukins
The endometrial epithelial mRNA expression of the
analyzed interleukins was only correlated to the current uterine
health status. A long-term effect of the health status was not
observed when diagnosed at E1.
IL1A mRNA was correlated to the health status at E1, E3CH
and E4CH (Fig. 5A). In comparison to the H group it was
expressed about six- to sevenfold higher in cows with SCE, both
at E1 (P = 0.02) and E3CH (P = 0.042). Later at E4CH, the
mRNA expression was 100-fold higher (P = 0.011) in CE cows
in comparison to the H group, but no significant differences for
the SCE group were observed.
IL1B mRNA was higher expressed in cows with SCE at the
early (E1; 15-fold higher; P = 0.006) and late (E4CH; 20-fold
higher; P = 0.002) stage of the selected puerperial period. In
addition and similar to IL1A expression, the highest fold change
was observed also at E4CH in samples from cows with CE (200-
fold higher; P = 0.003) in relation to the H group (Fig. 5B).
The transcript amounts of IL6 were twofold higher (P =
0.023) in SCE cows at E3CH and sixfold higher (P = 0.022) in
cows with CE at E4CH, both related to the H group (Fig. 5C).
The IL8 mRNA expression pattern showed significant
differences between the same groups at the same points in time
of sampling as shown for IL1A, with the addition of a higher
content of IL8 mRNA in uterine samples from SCE cows
compared with H cows at E4CH (15-fold higher; P = 0.023)
(Fig. 5D). The expression was 25- and 10-fold higher in SCE
cows at E1 (P = 0.006) and E3CH (P = 0.012), respectively.































































Fig. 3. Normalized mRNA
expression of (A) PTGIS and (B)
PTGDS in bovine endometrial
cytobrush samples harvested from
dairy cows depending on the status
of uterine health (H: healthy, SCE:
subclinical endometritis, CE:
clinical endometritis) on days 24-
30 pp (E1), on days 31-37 pp
(E2/E2CH), on days 38-44 pp
(E3/E3CH) and on days 45-51 pp
(E4/E4CH). Bold asterisks over
dotted lines indicate significant
differences between the groups (P <
0.05). Extreme values are





























































































































Fig. 4. Normalized mRNA
expression of (A) CXCL1/2, (B)
CXCL3, (C) CXCL5 and (D)
CXCR2 in bovine endometrial
cytobrush samples harvested
from dairy cows depending on
the status of uterine health (H:
healthy, SCE: subclinical
endometritis, CE: clinical
endometritis) on days 24-30 pp
(E1), on days 31-37 pp
(E2/E2CH), on days 38-44 pp
(E3/E3CH) and on days 45-51 pp
(E4/E4CH). Bold asterisks over
dotted lines indicate significant
differences between the groups
(P < 0.05). Extreme values are
diagrammed as asterisks, outliers
as circles. Extreme values are not
shown for CXCL1/2 (134.53) and
CXCR2 (321.89) obtained from a
cow in the CE group at E4/E4CH
and CXCL5 (24.24) obtained
from a cow in the SCE group at
E4 and in the CE group at E4CH.
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fold change (120-fold) in the CE group in relation to healthy
cows was observed at E4CH (P = 0.002).
mRNA expression of tumor necrosis factor (TNF), matrix
metallopeptidase 1 (MMP1) and platelet-activating factor
receptor (PTAFR)
For the transcript amount of these selected candidate genes
significant differences were also noted if the current uterine
health status was considered.
The mRNA expression of TNF in luminal endometrial
epithelium was affected at E3CH and E4CH (Fig. 6A). At E3CH,
TNF was higher (P = 0.034) expressed in cows with SCE and at
E4CH, the mRNA content of TNF was 15-fold higher (P =
0.005) only in the CE group in comparison to the H group.
MMP1 mRNA expression was dependent on the current
health status starting on days 31-37 pp. Compared with the H
group, a higher mRNA expression was detected in CE cows at
E2CH (60-fold higher; P = 0.01), at E3CH (20-fold higher; P
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Fig. 5. Normalized mRNA expression of (A) IL1A, (B) IL1B, (C) IL6 and (D) IL8 in bovine endometrial cytobrush samples harvested from
dairy cows depending on the current status of uterine health (H: healthy, SCE: subclinical endometritis, CE: clinical endometritis) on days
24-30 pp (E1), on days 31-37 pp (E2CH), on days 38-44 pp (E3CH) and on days 45-51 pp (E4CH). Bold asterisks over dotted lines indicate
significant differences between the groups (P < 0.05). Extreme values are diagrammed as asterisks, outliers as circles. Extreme values are
not shown for IL1A (323.80) and IL1B (1897.99) obtained from a cow with CE at E1 and for IL1B (1901.71) from a cow with CE at E2CH.
Extreme values are also not shown for IL6 (16.83) and IL8
addition in SCE cows (180-fold higher; P = 0.047) at E4CH
(Fig. 6B).
In comparison to the H group, PTAFR was twofold higher (P
= 0.017) expressed in SCE cows at E1 (Fig. 6C). At E4CH, a
direct correlation of PTAFR mRNA expression to the uterine
health was observed with a higher expression in the endometrial
epithelium in both SCE cows (fivefold higher; P = 0.001) and CE
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Fig. 6. Normalized mRNA expression of (A) TNF, (B)
MMP1 and (C) PTAFR in bovine endometrial
cytobrush samples harvested from dairy cows
depending on the current status of uterine health (H:
healthy, SCE: subclinical endometritis, CE: clinical
endometritis) on days 24-30 pp (E1), on days 31-37 pp
(E2CH), on days 38-44 pp (E3CH) and on days 45-51
pp (E4CH). Bold asterisks over dotted lines indicate
significant differences between the groups (P < 0.05).
Extreme values are diagrammed as asterisks, outliers as
circles. One extreme values is not shown for MMP1
(107.35) obtained from a cow with CE at E1.
Correlation analysis
Significant correlations are listed in Table 2. The percentage
of PMN was highest correlated to mRNA expression of CXCR2,
IL1A, IL1B and IL8. PTGS1, PTGIS and PTGES3 were the only
investigated factors whose mRNA expression did not show
significant correlation to the number of PMN.
Especially the mRNA content of the factors that mainly
attract PMNs showed high correlations among each other
(IL1A, IL1B, IL8, CXCL1/2 and CXCR2) with the highest
correlation between IL1B and IL8 mRNA expression. In
contrast, the attractants for PMNs had none or only weak to
moderate correlations to the enzymes of the synthesis of
prostaglandins. IL1A, IL1B and IL8 were negatively correlated
to PTGIS.
The enzymes of the synthesis of PGs also showed either
none or mostly only weak to moderate correlations among each
other and to other factors. For PTGES3, no correlations at all
could be observed. The only enzyme of PG synthesis that is
correlated to all of the other groups (chemokines, interleukins,
TNF, MMP1 and PTAFR) is PTGS2.
DISCUSSION
The influence of the immune system on reproductive
processes in the female was reported for many species (32-35).
In the bovine, an upregulation of the local immune system for
the clearance of invaded bacteria and lochia as well as for the
repair of the epithelium is considered as a physiological process
in the early postpartum period as part of involution of the uterus.
This process often seems to be inefficient and the transition from
a physiological to a more pathological status is associated with a
shifted duration and severity of the immune response to later
stages of the puerperium (10).
Several former studies already correlated the mRNA
expression of pro-inflammatory factors to the uterine health, but
mainly focused on only one point in time of the puerperium.
Cows with clinical or subclinical endometritis had a higher
mRNA expression of pro-inflammatory factors on days 21-27 pp
(15, 19), on days 28-35 pp (36) and on days 28-41 pp (18).
However, the present study design allowed a repeated sampling
of the same cows. Therefore, it was possible to differentiate the
expression patterns of pro-inflammatory factors at different
points in time during a longer period of the puerperium (days 24-
51 pp). This provided additional information especially about
later stages of the puerperium.
The results show that in contrast to earlier points in time,
almost all of the analyzed factors (except PTGIS and PTGES3)
were affected by the uterine health status on days 45-51 pp.
Interestingly, the fold changes were mostly higher if compared
with earlier stages. This suggests that the severity of inflammation
might differ during the time course of the puerperium. Clinical and
subclinical endometritis on days 45-51 pp seem to cause a more
severe inflammatory response than at earlier stages. This is
supported by the findings of Galvao et al. (17) who also found an
increase of IL1B, IL6 and IL8 mRNA expression in uterine
biopsies from cows with endometritis around the same stage of the
puerperium (week 7 after calving), even though there were no
correlations to the uterine health at earlier stages. This implies that
gene analysis around days 45-51 pp might be more informative
when correlating pro-inflammatory factors to subclinical and/or
clinical endometritis. When evaluating the effect of new
applicable therapy strategies for bovine uterine diseases, this
impact of the point in time of the puerperium on the mRNA
expression pattern should be considered.
In this context, especially the enzymes for the PG synthesis
seem to be of special interest. Although PTGS2 mRNA
expression showed a puerperal time-dependency with a
significant peak on day 17 pp (14), another study did not reveal
a dependency on the expression of PTGS2 mRNA to the uterine
health for the earlier puerperal stage (days 21-27 pp) (15).
However, the results of the present study show that PTGS1,
PTGS2 and PTGDS were affected on days 45-51 pp. This
suggests that the inflammatory response seems to be delayed on
the part of PG production. Although enzymes of the synthesis of
PGs did not show a significant dependency on the uterine health
status on days 24-30 pp, the mRNA expression of PTGDS was
affected on days 31-44 pp and of PTGIS on days 38-44 pp in
cows with CE if referring to the initial grouping. Similar long-
term effects failed to appear for most of the other analyzed
factors. However, it has to be considered that cows with CE were
injected with PGF2α after the sampling on days 24-30 pp (E1)
and on days 38-44 pp (E3). Therefore, an effect of the first PGF2α
injection on the increased mRNA expression of PTGDS and
PTGIS cannot be excluded.
A special role among the PGs regarding reproductive events is
awarded to PGE2. A dysregulated too high production in
combination with its luteotrophic effect (37) might lead to
disrupted luteolysis and a prolonged luteal phase (38). High
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  PMN PTGS1 PTGS2 PTGIS PTGES3 PTGDS CXCL1/2 CXCR2 CXCL3 CXCL5 IL1A IL1B IL6 IL8 TNF MMP1 PTAFR 
PMN    0.280   0.360 0.552 0.704 0.323 0.545 0.675 0.655 0.484 0.634 0.378 0.493 0.587 
PTGS1    0.409  0.407           0.311 
PTGS2 0.280      0.311 0.338 0.312 0.240 0.314 0.366 0.357 0.453 0.340 0.375 0.319 0.366 
PTGIS  0.409     0.284     - 0.252 - 0.276  - 0.354    
PTGES3                   
PTGDS 0.360 0.407 0.311 0.284     0.420  0.420 0.306 0.402 0.237 0.258 0.323 0.350 0.500 
CXCL1/2 0.552  0.338      0.802 0.694 0.779 0.807 0.803 0.610 0.835 0.483 0.471 0.718 
CXCR2 0.704  0.312   0.420 0.802   0.462 0.738 0.791 0.877 0.598 0.843 0.473 0.506 0.740 
CXCL3 0.323  0.240    0.694 0.463   0.618 0.526 0.487 0.413 0.509 0.436 0.368 0.467 
CXCL5 0.545  0.314   0.420 0.779 0.738 0.618   0.702 0.718 0.523 0.699 0.553 0.500 0.696 
IL1A 0.675  0.366 - 0.252  0.306 0.807 0.791 0.526 0.702   0.851 0.604 0.872 0.530 0.602 0.715 
IL1B 0.655  0.357 - 0.276  0.402 0.803 0.877 0.487 0.718 0.851   0.645 0.887 0.476 0.515 0.660 
IL6 0.484  0.453   0.237 0.610 0.598 0.413 0.523 0.604 0.645   0.624 0.370 0.485 0.484 
IL8 0.634  0.340 - 0.354  0.258 0.835 0.843 0.509 0.699 0.872 0.887 0.624   0.459 0.552 0.608 
TNF 0.378  0.375   0.323 0.483 0.473 0.436 0.553 0.530 0.476 0.370 0.459   0.389 0.591 
MMP1 0.493  0.319   0.350 0.471 0.506 0.368 0.500 0.602 0.515 0.485 0.552 0.389   0.519 
PTAFR 0.587 0.311 0.366     0.500 0.781 0.740 0.467 0.696 0.715 0.660 0.484 0.608 0.591 0.519   

Table 2. Significant correlation coefficients between the content of PMN with the mRNA expression of the selected factors as well as
between each of the factors in endometrial cytobrush samples during days 24-51 pp presented as a matrix format (P < 0.01). When no
value was indicated, no significant correlation was observed.
concentrations of PGE2 in the peripheral blood plasma, stimulated
by the administration of a high dose of TNF, prolonged the estrous
cycle in dairy cows (39). Extended postpartum luteal phases can
be linked to uterine diseases (40), probably caused by the switch
of the secretion from PGF2α to PGE2 after bacterial infection (41),
whereas the absolute concentrations might be less decisive than
the resulting higher PGE2/PGF2α ratio (42). Baranski et al. (43)
found a significantly higher content of PGE2 in cytobrush samples
from cows with clinical endometritis on days 21-28 pp. Another
study showed significantly higher concentrations of PGE2 in the
uterine fluid of cows with severe clinical endometritis compared
with mild endometritis cases (44). In addition, a significantly
stimulated PGE2 output from endometrial tissue in the luteal phase
or early pregnancy after the addition of pro-inflammatory IL1A as
being a potent stimulator on PG production in bovine endometrial
stromal cells was observed (45-47). In this context, peroxisome
proliferator activated receptors were shown to be mediators for
PGE2 release from porcine endometrial explants harvested during
the luteal phase of the estrous cycle or during the time of
implantation (48).
However, a dependency on the mRNA expression of
PTGES3 on the uterine health status during the whole period
(days 24-51 pp) was not observed in the present study. Thereby,
it has to be considered that there are three different synthases for
PGE2. While PTGES1 can especially be linked to inflammation,
female reproduction and tissue repair, PTGES2 and PTGES3 are
more constitutive and unaffected by pro-inflammatory stimuli
(49). Therefore, PTGES1 mRNA expression analysis on days
24-51 pp should be of prospective interest.
The results of the microbiological analysis suggest that a
sampling at a later stage of the puerperium is not expedient. On
days 45-51 pp, almost no pathogenic bacteria at all could be
detected, even if cows had purulent vaginal discharge. Therefore,
no correlations to the health groups were found in strong contrast
to the mRNA expression analysis. Consistent with the finding of
Westermann et al. (50) who showed a significant increased
number of samples positive for T. pyogenes in relation to
increasing vaginal discharge score, T. pyogenes was found more
often in cows with CE in the present study, but only on days 24-
30 pp. Interestingly, cows positive for T. pyogenes mainly
remained in either the SCE or CE group afterwards. In contrast, all
cows positive for E. coli on days 24-30 pp switched to the H
group. This is comparable to the results of Sens and Heuwieser
(51) whose study revealed the higher odds of having >18% PMN
on 21-27 days in milk (DIM) for cows with a T. pyogenes infection
at 10 ± 1 DIM, but that an E. coli infection at 10 ± 1 DIM had no
effect on the prevalence of SCE later in the puerperium. Thereby
it has to be considered that the detected E. coli may belong to
rather non-pathogenic strains than to endometrial pathogenic E.
coli (52). In addition, there were also no bacteriological findings
with significant prevalence for the SCE group. This supports the
statement of McDougall et al. (53) that the quantification of the
percentage of PMN in endometrial cytology is better suitable to
predict reproductive performance than conventional intra-uterine
bacteriology or the scoring of vaginal contents.
In conclusion, the attempt of revealing possible long-term
effects of the initial uterine health status on days 24-30 pp on the
subsequent mRNA expression pattern of the candidate genes
showed effects on chemokines, PTGDS and PTGIS. If correlated
to the current uterine health at each sampling, mRNA expression
analysis of pro-inflammatory factors suggests a different
severity of inflammatory response during days 24-51 pp with the
strongest immune response at the later stage (on days 45-51 pp).
In contrast, microbiological analysis of uterine samples was not
meaningful around that time of the puerperium.
The present study contributes to a better understanding of
inflammatory processes in the puerperal bovine endometrium,
which might help with the development of new strategies of
treatment for endometritis. However, the supposed differences in
the severity of inflammatory response shown by the mRNA
expression patterns should be substantiated by analyzing protein
levels in a prospective study.
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